PRMT5 disruption drives antitumor immunity in cervical cancer by reprogramming T cell-mediated response and regulating PD-L1 expression.
Autor: | Yongshuai Jiang, Yuanyang Yuan, Ming Chen, Shengzhe Li, Jun Bai, Yuanteng Zhang, Ying Sun, Guojue Wang, Haiyan Xu, Ziyu Wang, Yingxia Zheng, Hong Nie |
---|---|
Zdroj: | Theranostics; 2021, Vol. 11 Issue 18, p9162-9176, 15p |
Databáze: | Complementary Index |
Externí odkaz: |